MedTrace Logo

Clinical Significance and Prognostic Value of Prenatal Diagnosis of Obliteration of the Cavum Septum Pellucidum

NCT06782802 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-01-20

No results posted yet for this study

Summary

The aim of this observational study is to evaluate the incidence of the occurrence of additional abnormalities in fetuses diagnosed with cavum septum pellucidum (CSP) obliteration performed at second-trimester ultrasound, as well as to analyze the postnatal neurological outcome.

Conditions

  • Fetal Neurodevelopmental Disorder
  • Cavum Septum Pellucidum

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Gianluigi Pilu, MD · IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility

Min Age
28 Days
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-07
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06782802 on ClinicalTrials.gov